SCHEDULE 13G/A: BlackRock Discloses 7.8% Stake in Teladoc Health Inc. via Amended Schedule 13G

BlackRock, Inc. has filed an amended Schedule 13G, reporting a 7.8% beneficial ownership stake in Teladoc Health Inc. as of March 31, 2025.

Summary

• BlackRock, Inc. filed an Amendment No. 10 to Schedule 13G regarding its beneficial ownership in Teladoc Health Inc.
• As of March 31, 2025, BlackRock, Inc. beneficially owns 13,556,351 shares of Teladoc Health Inc. Common Stock.
• This ownership represents 7.8% of the class of securities.
• BlackRock, Inc. holds sole voting power over 13,259,623 shares and sole dispositive power over 13,556,351 shares.
• No shared voting or dispositive power is reported.
• The shares were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of Teladoc Health Inc.
• Various BlackRock subsidiaries have the right to receive dividends or proceeds from the sale of these securities, but no single subsidiary holds more than five percent of the total outstanding common shares.

Sentiment

Score: 5

Explanation: The document is a factual disclosure of ownership, carrying a neutral sentiment. The presence of a large institutional investor like BlackRock could be seen as positive, but the filing itself is purely informational.

Positives

• The disclosure of a significant 7.8% stake by a major institutional investor like BlackRock, Inc. can signal confidence in Teladoc Health Inc.'s long-term prospects.
• The filing confirms that BlackRock's investment is for ordinary course business purposes and not an attempt to influence or change control of the issuer, providing stability.

Future Outlook

This Schedule 13G filing is a disclosure of current ownership and does not contain any forward-looking statements or guidance regarding Teladoc Health Inc.'s future performance or BlackRock's investment strategy beyond the certification of ordinary course business holdings.

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §§ 240.14a-11."

Industry Context

This filing is a routine disclosure of institutional ownership and does not provide specific analysis of broader industry trends or Teladoc Health Inc.'s competitive position within the healthcare technology or telehealth sectors.

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant institutional investor's stake in Teladoc Health Inc., which can influence market perception and trading activity.
• Company Management: Informs Teladoc Health Inc. management of BlackRock's substantial, passive investment position.

Key Dates

Keywords

Teladoc Health Inc., BlackRock Inc., Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, Healthcare Technology, Telehealth